Skip to main content

Packaging, labelling and marketing of pharmaceuticals has evolved rapidly in India, with concerns about ‘deceptive similarity’ at the helm. Our Pharma Dossier (Vol. 1) discusses trade mark jurisprudence in light of the primary factor – the consumer.

Whereas differentiation on the basis of a name may have become more constrictive, creative use of unconventional marks and branding exercises by pharmaceutical companies has aided the creation of unique identities. Useful, with the rate e-pharmacies are disrupting traditional distribution models.

 

To read more, contact us at email@anandandanand.com

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
Mar 18, 2026

First published by Lexology. Authors: Safir Anand and Sehr Anand Intellectual property Design protection Which IP rights are applicable to fashion designs?

Snapshot: intellectual property for fashion goods in India
News & Updates
Mar 11, 2026

IP Feast, a unique initiative conceptualised by Safir Anand, Senior Partner, Anand and Anand, has been featured in HELLO! Magazine. The feature highlights

IP Feast Featured in HELLO! Magazine
News & Updates, Thought Leadership
Mar 10, 2026

‘First published on BW Legal World’ By: Safir Anand, Mudit Kaushik and Sehr Anand India has strong design talent, ranging from local craftspeople to

Not Just Made in India – Designed in India The Budget’s Most Strategic Move
News & Updates, Thought Leadership
Mar 10, 2026

‘First published on BW Legal World’ By: Pravin Anand and Dr. Ajai Garg The Summit underscored a broader reality: artificial intelligence is no longer

India AI Impact Summit 2026: Law, Leadership, and India’s AI Moment